Tick-borne Encephalitis Vaccine Market

The major factors that drive the growth of global tick-borne encephalitis vaccine, inactivated market is rise in prevalence of tick-borne encephalitis, especially in Europe, and increased government funding on healthcare facilities. In addition, increase in drug development owing to technological advancement in the medical sector fuels the market growth. However, high cost of vaccines is the major restraint of the market. On the contrary, untapped economies with unmet medical needs is anticipated to provide lucrative opportunities for market growth.

Tick-borne Encephalitis Vaccine Market contains market size and forecasts of Tick-borne Encephalitis Vaccine in global, including the following market information:

• Global Tick-borne Encephalitis Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Tick-borne Encephalitis Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
• Global top five Tick-borne Encephalitis Vaccine companies in 2021 (%)

The global Tick-borne Encephalitis Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

European TBE Virus Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tick-borne Encephalitis Vaccine include Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus and Superdrug Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tick-borne Encephalitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tick-borne Encephalitis Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Tick-borne Encephalitis Vaccine Market Segment Percentages, by Type, 2021 (%)

• European TBE Virus
• Far Eastern TBE Virus
• Siberian TBE Virus

Global Tick-borne Encephalitis Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Tick-borne Encephalitis Vaccine Market Segment Percentages, by Application, 2021 (%)

• Pediatric Vaccines
• Adult Vaccines
• Traveler Vaccines

Global Tick-borne Encephalitis Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Tick-borne Encephalitis Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Tick-borne Encephalitis Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Tick-borne Encephalitis Vaccine revenues share in global market, 2021 (%)
• Key companies Tick-borne Encephalitis Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
• Key companies Tick-borne Encephalitis Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Encephalitis
• Cochrane Collaboration
• Sonic HealthPlus
• Superdrug Health